Publications

Found 3 results
Filters: Author is A.L.B. Godard  [Clear All Filters]
2011
E. R. Valadares, Trindade, A. L. C., Oliveira, L. R., Godard, A. L. B., Arantes, R. R., Daker, M. V., Viana, B. M., Haase, V. G., Jardim, L. B., and Lopes, G. C., Novel exon nucleotide deletion causes adrenoleukodystrophy in a Brazilian family, vol. 10, pp. 65-74, 2011.
Berger J, Molzer B, Fae I and Bernheimer H (1994). X-linked adrenoleukodystrophy (ALD): a novel mutation of the ALD gene in 6 members of a family presenting with 5 different phenotypes. Biochem. Biophys. Res. Commun. 205: 1638-1643. http://dx.doi.org/10.1006/bbrc.1994.2855 PMid:7811247   Bezman L, Moser AB, Raymond GV, Rinaldo P, et al. (2001). Adrenoleukodystrophy: incidence, new mutation rate, and results of extended family screening. Ann. Neurol. 49: 512-517. http://dx.doi.org/10.1002/ana.101 PMid:11310629   Blaw ME (1970). Melanodermic Type Leucodystrophy (Adrenoleukodystropy). In: Leucodystrophies and Poliodystrophies (Vinken PJ and Bruyn GWE, eds.). North Holland Publishing, Amsterdam, 128-133.   Boehm CD, Cutting GR, Lachtermacher MB, Moser HW, et al. (1999). Accurate DNA-based diagnostic and carrier testing for X-linked adrenoleukodystrophy. Mol. Genet. Metab. 66: 128-136. http://dx.doi.org/10.1006/mgme.1998.2779 PMid:10068516   Dean M and Santis G (1994). Heterogeneity in the severity of cystic fibrosis and the role of CFTR gene mutations. Hum. Genet. 93: 364-368. http://dx.doi.org/10.1007/BF00201659 PMid:7513291   Eichler EE, Budarf ML, Rocchi M, Deaven LL, et al. (1997). Interchromosomal duplications of the adrenoleukodystrophy locus: a phenomenon of pericentromeric plasticity. Hum. Mol. Genet. 6: 991-1002. http://dx.doi.org/10.1093/hmg/6.7.991 PMid:9215666   El-Deiry SS, Naidu S, Blevins LS and Ladenson PW (1997). Assessment of adrenal function in women heterozygous for adrenoleukodystrophy. J. Clin. Endocrinol. Metab. 82: 856-860. http://dx.doi.org/10.1210/jc.82.3.856 PMid:9062496   Fanen P, Guidoux S, Sarde CO, Mandel JL, et al. (1994). Identification of mutations in the putative ATP-binding domain of the adrenoleukodystrophy gene. J. Clin. Invest. 94: 516-520. http://dx.doi.org/10.1172/JCI117363 PMid:8040304 PMCid:296124   Grosko AP and Ferreira RJ (2006). Aspectos biológicos e moleculares da adrenoleucodistrofia. Arq. Ciênc. Saúde Unipar 10: 43-47.   Higgins CF (1992). ABC transporters: from microorganisms to man. Annu. Ver. Cell Biol. 8: 67-113. http://dx.doi.org/10.1146/annurev.cb.08.110192.000435 PMid:1282354   Igarashi M, Schaumburg HH, Powers J, Kishmoto Y, et al. (1976). Fatty acid abnormality in adrenoleukodystrophy. J. Neurochem. 26: 851-860. http://dx.doi.org/10.1111/j.1471-4159.1976.tb04462.x PMid:965973   Jardim LB, da Silva AC, Blank D, Villanueva MM, et al. (2010). X-linked adrenoleukodystrophy: clinical course and minimal incidence in South Brazil. Brain Dev. 32: 180-190. http://dx.doi.org/10.1016/j.braindev.2009.02.002 PMid:19269120   Kemp S and Wanders RJ (2007). X-linked adrenoleukodystrophy: very long-chain fatty acid metabolism, ABC half-transporters and the complicated route to treatment. Mol. Genet. Metab. 90: 268-276. http://dx.doi.org/10.1016/j.ymgme.2006.10.001 PMid:17092750   Kok F, Neumann S, Sarde CO, Zheng S, et al. (1995). Mutational analysis of patients with X-linked adrenoleukodystrophy. Hum. Mutat. 6: 104-115. http://dx.doi.org/10.1002/humu.1380060203 PMid:7581394   Korenke GC, Fuchs S, Krasemann E, Doerr HG, et al. (1996). Cerebral adrenoleukodystrophy (ALD) in only one of monozygotic twins with an identical ALD genotype. Ann. Neurol. 40: 254-257. http://dx.doi.org/10.1002/ana.410400221 PMid:8773611   Lachtermacher MB, Seuanez HN, Moser AB, Moser HW, et al. (2000). Determination of 30 X-linked adrenoleukodystrophy mutations, including 15 not previously described. Hum. Mutat. 15: 348-353. http://dx.doi.org/10.1002/(SICI)1098-1004(200004)15:4<348::AID-HUMU7>3.0.CO;2-N   Loes DJ, Fatemi A, Melhem ER, Gupte N, et al. (2003). Analysis of MRI patterns aids prediction of progression in X-linked adrenoleukodystrophy. Neurology 61: 369-374. http://dx.doi.org/10.1212/01.WNL.0000079050.91337.83 PMid:12913200   Mahmood A, Dubey P, Moser HW and Moser A (2005). X-linked adrenoleukodystrophy: therapeutic approaches to distinct phenotypes. Pediatr. Transplant. 9 (Suppl 7): 55-62. http://dx.doi.org/10.1111/j.1399-3046.2005.00447.x PMid:16305618   Miller SA, Dykes DD and Polesky HF (1988). A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16: 1215. http://dx.doi.org/10.1093/nar/16.3.1215 PMid:3344216 PMCid:334765   Montagna G, Di Biase A, Cappa M, Melone MA, et al. (2005). Identification of seven novel mutations in ABCD1 by a DHPLC-based assay in Italian patients with X-linked adrenoleukodystrophy. Hum. Mutat. 25: 222. http://dx.doi.org/10.1002/humu.9303 PMid:15643618   Moser AB, Kreiter N, Bezman L, Lu S, et al. (1999). Plasma very long chain fatty acids in 3,000 peroxisome disease patients and 29,000 controls. Ann. Neurol. 45: 100-110. http://dx.doi.org/10.1002/1531-8249(199901)45:1<100::AID-ART16>3.0.CO;2-U   Moser HW (2006). Therapy of X-linked adrenoleukodystrophy. NeuroRx 3: 246-253. http://dx.doi.org/10.1016/j.nurx.2006.01.004 PMid:16554262   Moser HW and Moser AB (1996). Peroxisomal disorders: overview. Ann. N. Y. Acad. Sci. 804: 427-441. http://dx.doi.org/10.1111/j.1749-6632.1996.tb18634.x PMid:8993562   Moser HW, Moser AB, Frayer KK, Chen W, et al. (1981). Adrenoleukodystrophy: increased plasma content of saturated very long chain fatty acids. Neurology 31: 1241-1249. http://dx.doi.org/10.1212/WNL.31.10.1241 PMid:7202134   Moser HW, Powers JM and Smith KD (1995). Adrenoleukodystrophy: molecular genetics, pathology, and Lorenzo's oil. Brain Pathol. 5: 259-266. http://dx.doi.org/10.1111/j.1750-3639.1995.tb00602.x PMid:8520725   Moser HW, Smith KD, Watkins PA, Powers J, et al. (2001). X-linked Adrenoleukodystrophy. In: The Metabolic and Molecular Bases of Inherited Disease (Scriver CR, Beaudet AL, Sly WS and Valle D, eds.). McGraw Hill, New York, 3257-3301.   Moser HW, Mahmood A and Raymond GV (2007). X-linked adrenoleukodystrophy. Nat. Clin. Pract. Neurol. 3: 140-151. http://dx.doi.org/10.1038/ncpneuro0421 PMid:17342190   Mosser J, Douar AM, Sarde CO, Kioschis P, et al. (1993). Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters. Nature 361: 726-730. http://dx.doi.org/10.1038/361726a0 PMid:8441467   Pan H, Xiong H, Wu Y, Zhang YH, et al. (2005). ABCD1 gene mutations in Chinese patients with X-linked adrenoleukodystrophy. Pediatr. Neurol. 33: 114-120. http://dx.doi.org/10.1016/j.pediatrneurol.2005.03.006 PMid:16087056   Peters C, Charnas LR, Tan Y, Ziegler RS, et al. (2004). Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999. Blood 104: 881-888. http://dx.doi.org/10.1182/blood-2003-10-3402 PMid:15073029   Siemerling E and Creutzfeldt HG (1923). Bronzekrankheit und sklerosierende Encephalomyelitis. Arch. Psychiatr. Nervkrankh. 68: 217-244. http://dx.doi.org/10.1007/BF01835678   Smith KD, Sack G, Beaty T, Bergin A, et al. (1991). A genetic basis for the multiple phenotypes of X-linked adrenoleukodystrophy. Am. J. Hum. Genet. 49 (Suppl): 165.   van der Knaap MS and Valk J (2005). X-linked Adrenoleukodystrophy. In: Magnetic Resonance of Myelination and Myelin Disorders (van der Knaap MS and Valk J, eds.). 3rd edn. Springer, New York, 176-190.   van Geel BM, Assies J, Weverling GJ and Barth PG (1994). Predominance of the adrenomyeloneuropathy phenotype of X-linked adrenoleukodystrophy in The Netherlands: a survey of 30 kindreds. Neurology 44: 2343-2346. http://dx.doi.org/10.1212/WNL.44.12.2343 PMid:7991123   van Geel BM, Koelman JH, Barth PG and Ongerboer de Visser BW (1996). Peripheral nerve abnormalities in adrenomyeloneuropathy: a clinical and electrodiagnostic study. Neurology 46: 112-118. http://dx.doi.org/10.1212/WNL.46.1.112 PMid:8559356   van Geel BM, Bezman L, Loes DJ, Moser HW, et al. (2001). Evolution of phenotypes in adult male patients with X-linked adrenoleukodystrophy. Ann. Neurol. 49: 186-194. http://dx.doi.org/10.1002/1531-8249(20010201)49:2<186::AID-ANA38>3.0.CO;2-R   van Roermund CW, Visser WF, Ijlst L, van Cruchten A, et al. (2008). The human peroxisomal ABC half transporter ALDP functions as a homodimer and accepts acyl-CoA esters. FASEB J. 22: 4201-4208. http://dx.doi.org/10.1096/fj.08-110866 PMid:18757502